85 related articles for article (PubMed ID: 23999009)
1. Advanced malignant insulinoma. Everolimus response and toxicity.
Cuesta Hernández M; Gómez Hoyos E; Marcuello Foncillas C; Sastre Valera J; Díaz Pérez JÁ
Endocrinol Nutr; 2014 Jan; 61(1):e1-3. PubMed ID: 23999009
[No Abstract] [Full Text] [Related]
2. Efficacy of everolimus in patients with metastatic insulinoma and refractory hypoglycemia.
Bernard V; Lombard-Bohas C; Taquet MC; Caroli-Bosc FX; Ruszniewski P; Niccoli P; Guimbaud R; Chougnet CN; Goichot B; Rohmer V; Borson-Chazot F; Baudin E;
Eur J Endocrinol; 2013 May; 168(5):665-74. PubMed ID: 23392213
[TBL] [Abstract][Full Text] [Related]
3. Balancing efficacy and adverse reactions using everolimus in a patient with metastatic malignant insulinoma: Case report.
Rouf S; Boujtat K; El Harroudi T; Latrech H
Int J Clin Pharmacol Ther; 2024 Jun; 62(6):278-283. PubMed ID: 38431828
[TBL] [Abstract][Full Text] [Related]
4. Everolimus dramatically improves glycemic control in unresectable metastatic insulinoma: a case report.
Asayama M; Yamada-Murano T; Hara H; Ooki A; Kurosumi M; Yamaguchi K
Jpn J Clin Oncol; 2014 Feb; 44(2):186-90. PubMed ID: 24367043
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of the combination of carboplatin and cyclophosphamide in the treatment of metastatic insulinoma.
Marsh RW; Killeen RB
Cancer Invest; 1992; 10(6):523-4. PubMed ID: 1422889
[No Abstract] [Full Text] [Related]
6. Management of a metastasized high grade insulinoma (G3) with refractory hypoglycemia: case report and review of the literature.
Scharf M; Mueller D; Koenig U; Pfestroff A; Nimphius W; Figiel J; Rinke A; Koenig A; Gress T
Pancreatology; 2014; 14(6):542-5. PubMed ID: 25459566
[TBL] [Abstract][Full Text] [Related]
7. Malignant insulinoma: 18F-DOPA and 68Ga-DOTATATE PET/CT and treatment with 177Lu-DOTATATE.
Erhamamcı S; Sager S; Asa S; Uslu L; Akgun E; Sonmezoglu K
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(6):383-386. PubMed ID: 32487444
[No Abstract] [Full Text] [Related]
8. The Effect of Everolimus on Refractory Hypoglycemia in a Patient with Inoperable Metastatic Insulinoma Evaluated by Continuous Glucose Monitoring.
Yanagiya S; Cho KY; Nakamura A; Nomoto H; Kawamoto Y; Kawakubo K; Komatsu Y; Mitsuhashi T; Miyoshi H; Atsumi T
Intern Med; 2018 Sep; 57(17):2527-2531. PubMed ID: 29877259
[TBL] [Abstract][Full Text] [Related]
9. Pasireotide for malignant insulinoma.
Tirosh A; Stemmer SM; Solomonov E; Elnekave E; Saeger W; Ravkin Y; Nir K; Talmor Y; Shimon I
Hormones (Athens); 2016 Apr; 15(2):271-276. PubMed ID: 26732164
[TBL] [Abstract][Full Text] [Related]
10. [Malignant insulinoma is a rare cause of hypoglycemia].
Fokdal LU; Hansen F
Ugeskr Laeger; 2003 Mar; 165(14):1462-3. PubMed ID: 12715679
[TBL] [Abstract][Full Text] [Related]
11. Glycemic control in patients with insulinoma treated with everolimus.
Kulke MH; Bergsland EK; Yao JC
N Engl J Med; 2009 Jan; 360(2):195-7. PubMed ID: 19129539
[No Abstract] [Full Text] [Related]
12. Recurrence of Metastatic Pro-insulinoma Nearly 50 Years After Subtotal Pancreatectomy.
Romero Arenas MA; Olsen C; Yao JC
J Gastrointest Cancer; 2019 Jun; 50(2):345-348. PubMed ID: 29110229
[No Abstract] [Full Text] [Related]
13. [Treatment of metastatic malignant insulinomas. 2 cases].
Mounedji-Boudiaf L; Rougier P; Culine S; de Baere T; Lasser P; Escudier B; Ducreux M; Kaloustian E; Droz JP; Roche A
Presse Med; 1995 May; 24(19):894-6. PubMed ID: 7638129
[TBL] [Abstract][Full Text] [Related]
14. Therapies for the medical management of persistent hypoglycaemia in two cases of inoperable malignant insulinoma.
Ong GS; Henley DE; Hurley D; Turner JH; Claringbold PG; Fegan PG
Eur J Endocrinol; 2010 May; 162(5):1001-8. PubMed ID: 20164213
[TBL] [Abstract][Full Text] [Related]
15. [Islet cell carcinoma].
Lörincz I; Wórum F; Polgár P; Kovács P; Kozlovszky B; Péter M
Orv Hetil; 1987 Aug; 128(31):1623-6. PubMed ID: 3039440
[No Abstract] [Full Text] [Related]
16. Intra-arterial liver chemotherapy and hormone therapy in malignant insulinoma: case report and review of the literature.
Moscetti L; Saltarelli R; Giuliani R; Fornarini G; Bezzi M; Cortesi E
Tumori; 2000; 86(6):475-9. PubMed ID: 11218190
[TBL] [Abstract][Full Text] [Related]
17. Rapidly progressing malignant insulinoma presented with multiple liver metastases: a case report.
Erdogan A; Kose F; Akkaya H; Bascil Tutuncu N; Ozyilkan O
J Gastrointest Cancer; 2010 Dec; 41(4):272-4. PubMed ID: 20419482
[TBL] [Abstract][Full Text] [Related]
18. Nocardia brain abscess in a patient treated with everolimus for a metastatic insulinoma.
Walter T; Zadeh G; Hawryluk G; Krzyzanowska MK
J Clin Oncol; 2013 Feb; 31(6):e73-5. PubMed ID: 23182991
[No Abstract] [Full Text] [Related]
19. Everolimus resolving hypoglycemia, producing hyperglycemia, and necessitating insulin use in a patient with diabetes and nonresectable malignant insulinoma.
Ferrer-García JC; Tolosa-Torréns M; Hernando-Meliá C; Arribas-Palomar L; Sánchez-Juan C
Endocr Pract; 2011; 17(2):e17-20. PubMed ID: 21247848
[TBL] [Abstract][Full Text] [Related]
20. Everolimus induces rapid plasma glucose normalization in insulinoma patients by effects on tumor as well as normal tissues.
Fiebrich HB; Siemerink EJ; Brouwers AH; Links TP; Remkes WS; Hospers GA; de Vries EG
Oncologist; 2011; 16(6):783-7. PubMed ID: 21482586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
